Oral aniracetam treatment in C57BL/6J mice without pre-existing cognitive dysfunction reveals no changes in learning, memory, anxiety or stereotypy [version 3; referees: 2 approved, 1 approved with reservations]

Background: The piracetam analog, aniracetam, has recently received attention for its cognition enhancing potential, with minimal reported side effects.  Previous studies report the drug to be effective in both human and non-human models with pre-existing cognitive dysfunction, but few studies have...

Full description

Saved in:
Bibliographic Details
Main Authors: Conner D. Reynolds, Taylor S. Jefferson, Meagan Volquardsen, Ashvini Pandian, Gregory D. Smith, Andrew J. Holley, Joaquin N. Lugo
Format: Artigo
Language:Inglês
Published: F1000 Research Ltd 2018-06-01
Series:F1000Research
Subjects:
Behavioral Neuroscience
Cognitive Neuroscience
Online Access:https://f1000research.com/articles/6-1452/v3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items